Navigation Links
Epi-Foam Compression Foam, Designed for Post-Operative Liposuction Care, Only from Biodermis
Date:1/17/2013

HENDERSON, Nev., Jan. 17, 2013 /PRNewswire/ -- Epi-Foam is a unique, self-adhering medical grade silicone-backed post-operative compression foam device. It is worn immediately after both traditional and ultra-sonic liposuction procedures and provides a more even compression distribution. Improving compression distribution can assist in smoothing the skin and helping to reduce the "wavering" or "rippling" effect frequently associated with liposuction.  It can also help in reducing post-operative bruising and swelling.

Epi-Foam adheres gently to the skin by using the highest quality medical grade silicone. The adhesion is just enough to keep the pad in place, thus minimizing blistering or shearing.  Furthermore, silicone won't stick to the skin or cause pain and discomfort when removed, as typically experienced when using Reston™.

Unprecedented patient comfort is achieved by using only the most advanced soft, small cell, polyurethane materials to create the compression barrier between the patient's skin and the post-operative garment.  Polyurethane foam also provides for exceptional conformance to three-dimensional contours such as hips, waist, thighs, and chins.

"We believe Epi-Foam post-operative compression pads fill a gap in the post-operative recovery market, providing patients with unmatched comfort, minimized pain, and superior results that are simply not possible with any other product." 
Jeff Schleuning , Ph.D. EVP, Partner, Biodermis 

Each Epi-Foam pad is 7.75" x 11.50" and they are packaged in sets of three.

Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management and post-operative care industry for more than 25 years. For more information regarding Epi-Foam, log on at biodermis.com or call (702) 260-4466.

CONTACT: Sean Mahoney , Biodermis, (702) 260-4466


'/>"/>
SOURCE Biodermis
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
2. Paramedic Designed Auto Rescue Tool is a Top Holiday Gift Pick!
3. Life Technologies Announces Next-Gen Digital PCR Instrument Designed for Widespread Adoption
4. Jazz Pharmaceuticals Announces Support for National Campaign Designed to Curb Prescription Drug Abuse
5. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
6. BD Launches New Needle Designed to Improve Performance and Patient Comfort
7. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
8. Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV)
9. Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
10. Sentara Healthcare, MDLIVE Forge Unique Equity Partnership in Virtual Medicine
11. Save Up To 25% on International Biotech and Healthcare, and Pharmaceutical Conferences by Registering Through GII
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology:
(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, Inc., ... of SentinelSecure™, version 3.0, will be available in a managed cloud services model, ... SentinelSecure™ comes with several new enhancements including support for caller ID and network ...
(Date:9/25/2017)... ... 2017 , ... Nissar A. Darmani, PhD, has been awarded a record WesternU ... nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences in ... is from the National Cancer Institute (NCI) arm of the National Institutes of Health ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough to remember what ... headgear so wired up and containing so much metal that jokes about radio reception ... its treatments can barely be observed. As a result, it’s now a billion-dollar industry ...
(Date:9/25/2017)... ... September 25, 2017 , ... Winners in ... announced on Friday, September 22 during a gala event in New York City. ... achievements and HR-related products and suppliers who help to create and drive great ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on your average daily ... “more than any sane human could possibly complete,” then you’re all too familiar with ... desperately trying to be everything to everybody all the time. , Self-proclaimed overly productive ...
Breaking Medicine News(10 mins):